Rating: 
Summary: Excellent book
Review: Very good book. Excellent overview of the complex landscape of the biotech world. Simple and streight forward explanations. Logical structure and order of chapters. I would like to see some more case studies. What I appreciate most about this book is that it goes into technical information about the genome in much more depth than I expected for investors, still, without being too technical or difficult to the non biological educated reader.
Rating:
Summary: Biblical knowledge for investing in biotech stocks
Review: Wolff has written an excellent book on the biotechnology sector. He has combined great journalism skills to explain to us technicalities like "naked DNA", clinical trials, targets, genes sequencing etc.In addition to his journalism ability, he has given us a good feel of the 200 companies in the biotechnology sector. He has divided the sector into 4 type of companies that investors can relate with their risk and return profile. Do not expect to pick biotechnology stock winners with this book, as he has forewarned that biotechnology investing has an extremely long time horizon and fraud with risks like product failure, etc. He has also elaborated on how to read announcements by biotechnology companies that could enhance the potential of a product. With this book, I had a very good feel and knowledge of the sector. Overall, a good start for investors to begin with.
Rating:
Summary: Excellent book
Review: Wolff has written an excellent book on the biotechnology sector. He has combined great journalism skills to explain to us technicalities like "naked DNA", clinical trials, targets, genes sequencing etc. In addition to his journalism ability, he has given us a good feel of the 200 companies in the biotechnology sector. He has divided the sector into 4 type of companies that investors can relate with their risk and return profile. Do not expect to pick biotechnology stock winners with this book, as he has forewarned that biotechnology investing has an extremely long time horizon and fraud with risks like product failure, etc. He has also elaborated on how to read announcements by biotechnology companies that could enhance the potential of a product. With this book, I had a very good feel and knowledge of the sector. Overall, a good start for investors to begin with.
Rating:
Summary: Finally! A Thoughtful Investigation of Biotech Investing
Review: Wolff's seminal work is a treasure trove of information for the serious biotech investor. It is also a full-fledge reference for continuing study in the science that underlies the industry. Wolff adroitly circumvents the profusion of hype that currently engulfs much of the discussion of biotech investing today. Where so many so called biotech experts seem determined to enflame the irrational exuberance that has plagued this industry in the past, Wolff chooses instead to lead the interested investor to concrete data and careful analysis. As an investor disicnlined to throw money at chic trends, I benifited greatly from his meticulous segmentation of the biotech market. Such an approach allows for a clear and distinct understanding of the risks involved. His keen eye on the importance of diversification spoke to my conservative tendecies, while his analysis of particular bitoech companies provided the necessary confidence to make plays in this volitile areana. Wolff's decision to separate the work between biotech investing and biotech science was critical to its success as an enduring reference. One can get the financial information one needs now within the first section; deeper scientific understanding of the industry can be developed gradually, by returning to the second section to continue one's education. I recommend this work highly and without qualification.
| 
